logo

Quick Facts

Share SHARE

Johnson Controls (JCI) and Tyco International (TYC) announced the senior executive team that will lead the combined company following the close of their planned merger, which is expected on or around October 1, 2016. As previously announced, at the effective time of the merger, Johnson Controls chairman...

Merck & Co. Inc. (MRK) said that the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion recommending approval of ZEPATIER (elbasvir and grazoprevir), an investigational, once-daily, fixed-dose combination tablet for the treatment...

Gilead Sciences Inc. (GILD) announced that the Committee for Medicinal Products for Human Use or CHMP, the scientific committee of the European Medicines Agency or EMA, has adopted a positive opinion on the company's Marketing Authorization Application or MAA for Epclusa, an investigational, pan-genotypic,...

Amgen (AMGN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion to extend the current indication for Kyprolis or carfilzomib to include treatment in combination with dexamethasone alone for adult patients with multiple...

AstraZeneca (AZN.L, AZN) announced positive results from the Phase III FALCON trial comparing fulvestrant 500mg to anastrozole 1mg for the treatment of locally-advanced or metastatic breast cancer, in postmenopausal women who have not had prior hormonal treatment for hormone receptor positive or HR+...

Thermo Fisher Scientific Inc. (TMO) said that it agreed to buy FEI Company (FEIC) for $107.50 per share in cash. The transaction represents a purchase price of approximately $4.2 billion. FEI designs, manufactures and supports high-performance electron microscopy workflows that provide images and...

Big Lots, Inc. (BIG) announced that it expects second-quarter adjusted income from continuing operations to be in the range of $0.42 to $0.47 per share. Analysts polled by Thomson Reuters expect the company to report earnings of $0.45 per share for the second quarter. Analysts' estimates typically exclude...

Cameco Corp. (CCO.TO, CCJ) signed an agreement with Joint Stock Company National Atomic Company Kazatomprom and Joint Venture Inkai LLP to restructure and enhance JV Inkai. The new agreement replaces the memorandum of agreement signed by Cameco and Kazatomprom in September 2012. Cameco's ownership interest...

Mining company Anglo American Plc (AAUKY.PK, AAL.L) announced Friday the appointment of Bruce Cleaver as CEO of the De Beers Group. He succeeds Philippe Mellier, who has decided to step down after five years in the role. Duncan Wanblad, CEO of Anglo American's Base Metals business, will add the Strategy...

The Board of Wolseley plc (WOSCF.PK, WOS.L, WOSYY.PK) announced that Simon Nicholls will not take up his position as CFO, later in the current year. David Keltner, CFO of Ferguson Enterprises, the Group's US subsidiary, will be appointed as the Interim Group CFO on 1 September 2016. The selection process...

Genentech, a member of the Roche Group (RHHBY.PK), announced positive results from the pivotal Phase III GALLIUM study in people with previously untreated follicular lymphoma, the most common type of indolent (slow-growing) non-Hodgkin's lymphoma or iNHL. The study compared the efficacy and safety...

Titan Pharmaceuticals, Inc. (TTNP) announced that the U.S. Food and Drug Administration has approved Probuphine or buprenorphine implant, the first product for the long-term maintenance treatment of opioid dependence in clinically stable patients on 8 mg or less a day of oral buprenorphine. TTNP closed...

Brocade (BRCD) and Guiyang High-Tech Industrial Investment Group Co., Ltd or HTII, announced the signing of a joint venture agreement to establish Guizhou Huiling Technology Co., Ltd. or GHTC. The joint venture combines Brocade's data center networking solutions with Guiyang's leadership and innovation...

Japanese air bag maker Takata Corp. (TKTDF.PK), which is facing billions in possible costs for the biggest recall in automotive history, is in talks with potential buyers including KKR & Co., according to media reported citing people familiar with the matter. Talks are at a preliminary stage and KKR...

Minerva Neurosciences, Inc. (NERV) announced positive top line results from a prospective Phase IIb, 12-week, randomized, double-blind, placebo-controlled parallel clinical trial evaluating the efficacy, safety and tolerability of MIN-101 in patients with negative symptoms of schizophrenia.These negative...

Follow RTT